Clinical trial
Intravitreal Bevacizumab for Neovascular Glaucoma
NCT00384631 · Shahid Beheshti University of Medical Sciences, Other · Completed
Key facts
| NCT number | NCT00384631 |
|---|---|
| Title | Intravitreal Bevacizumab for Neovascular Glaucoma |
| Official title | Intravitreal Bevacizumab for Neovascular Glaucoma; a Randomized Placebo Controlled Clinical Trial |
| Acronym | IVB NVG |
| Lead sponsor | Shahid Beheshti University of Medical Sciences, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Neovascular, Glaucoma |
| Intervention type | Drug, Other |
| Interventions | subconjunctival normal saline, Avastin |
| Enrollment | 26 |
| Start date | Apr 1, 2006 |
| Completion | Mar 1, 2007 |
| First posted | Oct 6, 2006 |
| Last update posted | Feb 15, 2008 |
| Countries | Iran |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: